|
Market Closed -
Singapore S.E.
04:37:08 2026-09-09 EDT
|
5-day change | 1st Jan Change | ||
| 0.0260 SGD | -7.14% |
|
-7.14% | -13.33% |
| 08-12 | Progen Holdings Ltd Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 07-09 | Rani Therapeutics, PegBio Collaborate on Oral Delivery of Obesity Drugs | MT |
Company Valuation: Progen Holdings Ltd
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 14.45 | 17.18 | 18.35 | 19.14 | 11.72 | 11.72 |
| Change | - | 18.92% | 6.82% | 4.26% | -38.78% | 0% |
| Enterprise Value (EV) 1 | 16.85 | 19.56 | 21.38 | 13.41 | 5.21 | 5.467 |
| Change | - | 16.06% | 9.31% | -37.28% | -61.15% | 4.93% |
| P/E | -4.92x | -6.42x | 11.3x | -17.2x | -16.3x | -16.9x |
| PBR | 0.51x | 0.66x | 0.67x | 0.73x | 0.46x | 0.47x |
| PEG | - | 0.73x | -0x | 0x | 0.5x | 4.51x |
| Capitalization / Revenue | 4.79x | 4.35x | 3.5x | 4.34x | 2.06x | 2.31x |
| EV / Revenue | 5.59x | 4.96x | 4.08x | 3.04x | 0.91x | 1.08x |
| EV / EBITDA | -16.2x | -24.5x | -131x | -14.8x | -16.9x | 116x |
| EV / EBIT | -14.1x | -20.9x | -72.5x | -12.9x | -4.72x | -7.43x |
| EV / FCF | 83.6x | 173x | -2.16x | 1.51x | -34x | -61.4x |
| FCF Yield | 1.2% | 0.58% | -46.3% | 66.1% | -2.94% | -1.63% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.007513 | -0.006849 | 0.004174 | -0.002844 | -0.001843 | -0.001774 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 3.014 | 3.946 | 5.237 | 4.406 | 5.698 | 5.062 |
| EBITDA 1 | -1.043 | -0.799 | -0.163 | -0.906 | -0.308 | 0.047 |
| EBIT 1 | -1.192 | -0.934 | -0.295 | -1.036 | -1.104 | -0.736 |
| Net income 1 | -2.934 | -2.675 | 1.651 | -1.111 | -0.72 | -0.693 |
| Net Debt 1 | 2.405 | 2.379 | 3.029 | -5.723 | -6.505 | -6.248 |
| Reference price 2 | 0.0370 | 0.0440 | 0.0470 | 0.0490 | 0.0300 | 0.0300 |
| Nbr of stocks (in thousands) | 390,512 | 390,512 | 390,512 | 390,512 | 390,512 | 390,512 |
| Announcement Date | 4/13/21 | 4/12/22 | 4/13/23 | 4/8/24 | 4/4/25 | 4/9/26 |
1SGD in Million2SGD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 8.01M | |
| 56.24x | 2.59x | 24.73x | 0.07% | 97.81B | |
| 12.27x | 1.05x | 5.76x | 4.77% | 71.68B | |
| 26.31x | 2.02x | 19.89x | 1.17% | 56.38B | |
| 34.81x | 4.38x | 23.78x | 0.19% | 59.41B | |
| 50.68x | 4.03x | 25.66x | 1.8% | 40.39B | |
| 28.93x | 0.71x | 11.79x | 2.14% | 36.35B | |
| 23.83x | 1.63x | 15.02x | 0.19% | 34.43B | |
| 22.95x | 0.47x | 7.39x | 2.57% | 31.6B | |
| 5.02x | 0.31x | 5.81x | 5.85% | 26.79B | |
| Average | 29.00x | 1.91x | 15.54x | 2.08% | 45.48B | |
| Weighted average by Cap. | 32.34x | 2.14x | 17.01x | 1.8% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 583 Stock
- Valuation Progen Holdings Ltd
Select your edition
All financial news and data tailored to specific country editions
